J05AR18 emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat
ATC group of level 5 – chemical substance · in plain English: medicines against viruses, e.g. HIV or hepatitis
This site has the patient leaflet or the SPC of 2 medicines in this group.
- 2 prescription only (POM)
Place in the ATC classification
- J Antiinfectives for systemic use 1,393 medicines
- J05 Antivirals for systemic use 392 medicines
- J05A Direct acting antivirals 392 medicines
- J05AR Antivirals for treatment of HIV infections, combinations 80 medicines
- J05AR18 emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat 2 medicines
- J05AR Antivirals for treatment of HIV infections, combinations 80 medicines
- J05A Direct acting antivirals 392 medicines
- J05 Antivirals for systemic use 392 medicines
Active substances in the group
- Cobicistat 2 medicines
- Elvitegravir 2 medicines
- Emtricitabine 2 medicines
- Tenofovir alafenamide 2 medicines
Medicines
| Medicine | Legal category |
|---|---|
| Elvitegravir/cobicistat/emtricitabine/tenofovir Alafenamide Gilead 90 mg/90 mg/120 mg/6 mg tablets SPC | Prescription only (POM) |
| Genvoya 150 mg / 150 mg / 200 mg / 10 mg film-coated tablets SPC | Prescription only (POM) |
Other groups of the same level
- J05AR01 zidovudine and lamivudine 3 medicines
- J05AR02 lamivudine and abacavir 12 medicines
- J05AR03 tenofovir disoproxil and emtricitabine 15 medicines
- J05AR04 zidovudine, lamivudine and abacavir 2 medicines
- J05AR06 emtricitabine, tenofovir disoproxil and efavirenz 12 medicines
- J05AR08 emtricitabine, tenofovir disoproxil and rilpivirine 2 medicines
- J05AR09 emtricitabine, tenofovir disoproxil, elvitegravir and cobicistat 1 medicine
- J05AR10 lopinavir and ritonavir 6 medicines
- J05AR13 lamivudine, abacavir and dolutegravir 1 medicine
- J05AR14 darunavir and cobicistat 2 medicines
- J05AR15 atazanavir and cobicistat 2 medicines
- J05AR16 lamivudine and raltegravir 1 medicine
- J05AR17 emtricitabine and tenofovir alafenamide 10 medicines
- J05AR19 emtricitabine, tenofovir alafenamide and rilpivirine 2 medicines
- J05AR20 emtricitabine, tenofovir alafenamide and bictegravir 2 medicines
- J05AR22 emtricitabine, tenofovir alafenamide, darunavir and cobicistat 1 medicine
- J05AR24 lamivudine, tenofovir disoproxil and doravirine 1 medicine
- J05AR25 lamivudine and dolutegravir 1 medicine
Other names of the ATC group
- Czech: J05AR18 Emtricitabin, tenofovir-alafenamid, elvitegravir a kobicistat
- German: J05AR18 Emtricitabin, Tenofoviralafenamid, Elvitegravir und Cobicistat
- Italian: J05AR18 ELVITEGRAVIR/COBICISTAT/EMTRICITAMINA/TENOFOVIR ALAFENAMIDE
- Turkish: J05AR18 emtrisitabin, tenofovir alafenamid, elvitegravir ve kobisistat
- Portuguese (Brazil): J05AR18 Elvitegravir + Cobicistate + Emtricitabina + Tenofovir alafenamida
- German (Switzerland): J05AR18 Emtricitabin, Tenofoviralafenamid, Elvitegravir und Cobicistat
- Italian (Switzerland): J05AR18 Elvitegravir/cobicistat/emtricitamina/tenofovir alafenamide
Sources
- Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
- Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
- World Health Organization (WHO): ATC/DDD classification, group J05AR18
Contains public sector information licensed under the Open Government Licence v3.0.
Ask your doctor or pharmacist which medicine is right for you.